Fatty acid (FA)-stimulated insulin secretion (FASIS) is reviewed here in contrast to type 2 diabetes etiology, resulting from FA overload, oxidative stress, intermediate hyperinsulinemia, and inflammation, all converging into insulin resistance. Focusing on pancreatic islet β-cells, we compare the physiological FA roles with the pathological ones. Considering FAs not as mere amplifiers of glucose-stimulated insulin secretion (GSIS), but as parallel insulin granule exocytosis inductors, partly independent of the KATP channel closure, we describe the FA initiating roles in the prediabetic state that is induced by retardations in the glycerol-3-phosphate (glucose)-promoted glycerol/FA cycle and by the impaired GPR40/FFA1 (free FA1) receptor pathway, specifically in its amplification by the redox-activated mitochondrial phospholipase, iPLA2γ. Also, excessive dietary FAs stimulate intestine enterocyte incretin secretion, further elevating GSIS, even at low glucose levels, thus contributing to diabetic hyperinsulinemia. With overnutrition and obesity, the FA overload causes impaired GSIS by metabolic dysbalance, paralleled by oxidative and metabolic stress, endoplasmic reticulum stress and numerous pro-apoptotic signaling, all leading to decreased β-cell survival. Lipotoxicity is exerted by saturated FAs, whereas ω-3 polyunsaturated FAs frequently exert antilipotoxic effects. FA-facilitated inflammation upon the recruitment of excess M1 macrophages into islets (over resolving M2 type), amplified by cytokine and chemokine secretion by β-cells, leads to an inevitable failure of pancreatic β-cells.

Institute of Physiology of the Czech Academy of Sciences 14220 Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc19000630

003      

CZ-PrNML

005      

20200121142812.0

007      

ta

008      

190107s2018 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3390/molecules23061483 $2 doi

035    __

$a (PubMed)29921789

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Ježek, Petr $u Institute of Physiology of the Czech Academy of Sciences, 14220 Prague, Czech Republic. jezek@biomed.cas.cz.

245    10

$a Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity / $c P. Ježek, M. Jabůrek, B. Holendová, L. Plecitá-Hlavatá,

520    9_

$a Fatty acid (FA)-stimulated insulin secretion (FASIS) is reviewed here in contrast to type 2 diabetes etiology, resulting from FA overload, oxidative stress, intermediate hyperinsulinemia, and inflammation, all converging into insulin resistance. Focusing on pancreatic islet β-cells, we compare the physiological FA roles with the pathological ones. Considering FAs not as mere amplifiers of glucose-stimulated insulin secretion (GSIS), but as parallel insulin granule exocytosis inductors, partly independent of the KATP channel closure, we describe the FA initiating roles in the prediabetic state that is induced by retardations in the glycerol-3-phosphate (glucose)-promoted glycerol/FA cycle and by the impaired GPR40/FFA1 (free FA1) receptor pathway, specifically in its amplification by the redox-activated mitochondrial phospholipase, iPLA2γ. Also, excessive dietary FAs stimulate intestine enterocyte incretin secretion, further elevating GSIS, even at low glucose levels, thus contributing to diabetic hyperinsulinemia. With overnutrition and obesity, the FA overload causes impaired GSIS by metabolic dysbalance, paralleled by oxidative and metabolic stress, endoplasmic reticulum stress and numerous pro-apoptotic signaling, all leading to decreased β-cell survival. Lipotoxicity is exerted by saturated FAs, whereas ω-3 polyunsaturated FAs frequently exert antilipotoxic effects. FA-facilitated inflammation upon the recruitment of excess M1 macrophages into islets (over resolving M2 type), amplified by cytokine and chemokine secretion by β-cells, leads to an inevitable failure of pancreatic β-cells.

650    _2

$a zvířata $7 D000818

650    _2

$a mastné kyseliny $x metabolismus $7 D005227

650    _2

$a lidé $7 D006801

650    12

$a hyperinzulinismus $x metabolismus $x patologie $7 D006946

650    _2

$a inzulin $x metabolismus $7 D007328

650    12

$a inzulinová rezistence $7 D007333

650    _2

$a sekrece inzulinu $7 D000078790

650    12

$a beta-buňky $x metabolismus $x patologie $7 D050417

650    12

$a oxidační stres $7 D018384

655    _2

$a časopisecké články $7 D016428

655    _2

$a přehledy $7 D016454

700    1_

$a Jabůrek, Martin $u Institute of Physiology of the Czech Academy of Sciences, 14220 Prague, Czech Republic. martin.jaburek@fgu.cas.cz.

700    1_

$a Holendová, Blanka $u Institute of Physiology of the Czech Academy of Sciences, 14220 Prague, Czech Republic. blanka.holendova@fgu.cas.cz.

700    1_

$a Plecitá-Hlavatá, Lydie $u Institute of Physiology of the Czech Academy of Sciences, 14220 Prague, Czech Republic. lydie.plecita@fgu.cas.cz.

773    0_

$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 23, č. 6 (2018)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/29921789 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20190107 $b ABA008

991    __

$a 20200121143149 $b ABA008

999    __

$a ok $b bmc $g 1364674 $s 1038753

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2018 $b 23 $c 6 $e 20180619 $i 1420-3049 $m Molecules $n Molecules $x MED00180394

LZP    __

$a Pubmed-20190107